SCHEMBL2810741

SCHEMBL2810741

CCC(Br)[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4447065 0.76
SCHEMBL107704 0.69
SCHEMBL2686579 0.67
SCHEMBL20189043 0.67
SCHEMBL2510884 0.67 TSHR (0.39)
SCHEMBL5925278 0.67
SCHEMBL28936941 0.65
SCHEMBL10889954 0.63
SCHEMBL1600875 0.62
SCHEMBL4433963 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242159-B2 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation DONG-A PHARMACEUTICAL. CO., LTD (KR) 2012-08-14 US disclosed
CN-101910146-A Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation DONG A PHARM CO LTD 2010-12-08 CN disclosed
US-20100240725-A1 NOVEL 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION DONG-A PHARMACEUTICAL. CO., LTD (KR) 2010-09-23 US disclosed